BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37034598)

  • 1. Massively Parallel Profiling of RNA-targeting CRISPR-Cas13d.
    Kuo HC; Prupes J; Chou CW; Finkelstein IJ
    bioRxiv; 2023 Mar; ():. PubMed ID: 37034598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massively parallel profiling of RNA-targeting CRISPR-Cas13d.
    Kuo HC; Prupes J; Chou CW; Finkelstein IJ
    Nat Commun; 2024 Jan; 15(1):498. PubMed ID: 38216559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massively Parallel Biophysical Analysis of CRISPR-Cas Complexes on Next Generation Sequencing Chips.
    Jung C; Hawkins JA; Jones SK; Xiao Y; Rybarski JR; Dillard KE; Hussmann J; Saifuddin FA; Savran CA; Ellington AD; Ke A; Press WH; Finkelstein IJ
    Cell; 2017 Jun; 170(1):35-47.e13. PubMed ID: 28666121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massively parallel kinetic profiling of natural and engineered CRISPR nucleases.
    Jones SK; Hawkins JA; Johnson NV; Jung C; Hu K; Rybarski JR; Chen JS; Doudna JA; Press WH; Finkelstein IJ
    Nat Biotechnol; 2021 Jan; 39(1):84-93. PubMed ID: 32895548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
    Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
    Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas13d-Mediated Microbial RNA Knockdown.
    Zhang K; Zhang Z; Kang J; Chen J; Liu J; Gao N; Fan L; Zheng P; Wang Y; Sun J
    Front Bioeng Biotechnol; 2020; 8():856. PubMed ID: 32850723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of length and sequence of gRNA on Cas13b and Cas13d activity in vitro and in vivo.
    Liu Y; Jing P; Zhou Y; Zhang J; Shi J; Zhang M; Yang H; Fei J
    Biotechnol J; 2023 Sep; 18(9):e2300002. PubMed ID: 37148478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shotgun knockdown of RNA by CRISPR-Cas13d in fission yeast.
    Chen Z; Zheng S; Fu C
    J Cell Sci; 2023 Mar; 136(6):. PubMed ID: 36825467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
    Liu L; Pei DS
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d.
    Zhang C; Konermann S; Brideau NJ; Lotfy P; Wu X; Novick SJ; Strutzenberg T; Griffin PR; Hsu PD; Lyumkis D
    Cell; 2018 Sep; 175(1):212-223.e17. PubMed ID: 30241607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massively parallel CRISPRi assays reveal concealed thermodynamic determinants of dCas12a binding.
    Specht DA; Xu Y; Lambert G
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11274-11282. PubMed ID: 32376630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system.
    Elmore JR; Sheppard NF; Ramia N; Deighan T; Li H; Terns RM; Terns MP
    Genes Dev; 2016 Feb; 30(4):447-59. PubMed ID: 26848045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New PAM Improves the Single-Base Specificity of crRNA-Guided LbCas12a Nuclease.
    Misiurina MA; Chirinskaite AV; Fotina AS; Zelinsky AA; Sopova JV; Leonova EI
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36431062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding.
    Boyle EA; Andreasson JOL; Chircus LM; Sternberg SH; Wu MJ; Guegler CK; Doudna JA; Greenleaf WJ
    Proc Natl Acad Sci U S A; 2017 May; 114(21):5461-5466. PubMed ID: 28495970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d.
    Zhang B; Ye Y; Ye W; Perčulija V; Jiang H; Chen Y; Li Y; Chen J; Lin J; Wang S; Chen Q; Han YS; Ouyang S
    Nat Commun; 2019 Jun; 10(1):2544. PubMed ID: 31186424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive analysis of single nucleotide variation by Cas13d orthologs, EsCas13d and RspCas13d.
    Qiao X; Gao Y; Li J; Wang Z; Qiao H; Qi H
    Biotechnol Bioeng; 2021 Aug; 118(8):3037-3045. PubMed ID: 33964175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences.
    Lin Y; Cradick TJ; Brown MT; Deshmukh H; Ranjan P; Sarode N; Wile BM; Vertino PM; Stewart FJ; Bao G
    Nucleic Acids Res; 2014 Jun; 42(11):7473-85. PubMed ID: 24838573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
    Sharma S; Sharma CM
    Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.